- Home
- VIGL vs WRAP Comparison
VIGL vs WRAP Comparison
Compare VIGL & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- WRAP
- Stock Information
- Founded
- VIGL 2020
- WRAP 2016
- Country
- VIGL United States
- WRAP United States
- Employees
- VIGL N/A
- WRAP N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- WRAP Ordnance And Accessories
- Sector
- VIGL Health Care
- WRAP Industrials
- Exchange
- VIGL Nasdaq
- WRAP Nasdaq
- Market Cap
- VIGL 89.3M
- WRAP 91.2M
- IPO Year
- VIGL 2022
- WRAP N/A
- Fundamental
- Price
- VIGL $3.03
- WRAP $2.11
- Analyst Decision
- VIGL Strong Buy
- WRAP
- Analyst Count
- VIGL 5
- WRAP 0
- Target Price
- VIGL $21.00
- WRAP N/A
- AVG Volume (30 Days)
- VIGL 642.5K
- WRAP 163.9K
- Earning Date
- VIGL 03-25-2025
- WRAP 11-14-2024
- Dividend Yield
- VIGL N/A
- WRAP N/A
- EPS Growth
- VIGL N/A
- WRAP N/A
- EPS
- VIGL N/A
- WRAP N/A
- Revenue
- VIGL N/A
- WRAP $4,231,000.00
- Revenue This Year
- VIGL N/A
- WRAP N/A
- Revenue Next Year
- VIGL N/A
- WRAP N/A
- P/E Ratio
- VIGL N/A
- WRAP N/A
- Revenue Growth
- VIGL N/A
- WRAP N/A
- 52 Week Low
- VIGL $1.49
- WRAP $1.21
- 52 Week High
- VIGL $6.06
- WRAP $3.99
- Technical
- Relative Strength Index (RSI)
- VIGL 77.87
- WRAP 51.05
- Support Level
- VIGL $2.71
- WRAP $1.92
- Resistance Level
- VIGL $2.95
- WRAP $2.58
- Average True Range (ATR)
- VIGL 0.21
- WRAP 0.15
- MACD
- VIGL 0.03
- WRAP 0.02
- Stochastic Oscillator
- VIGL 86.18
- WRAP 28.79
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.